Data updated: Mar 29, 2026

ABIC

Oncology

Pharma

ABIC is a pharmaceutical company focused on Oncology.

-

Since

4

Drugs

-

Trials

22

Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues ProEarly access

Loading...

Revenue Over Time ProEarly access

Loading...

Recent Activity

FLUOROURACIL 2026-02-10

FLUOROURACIL 2026-02-10

FLUOROURACIL 2026-02-05

FLUOROURACIL 2026-02-05

FLUOROURACIL 2026-02-05

FLUOROURACIL 2026-02-05

FLUOROURACIL 2026-02-05

FLUOROURACIL 2026-02-05

SEC Filings ProEarly access

Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Oncology 100%

1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones ProEarly access

Loading...

Patent Cliff ProEarly access

Loading...

Competitors by Therapeutic Area

Pfizer big-pharma

Novartis big-pharma

Merck big-pharma

Baxter specialty

AbbVie big-pharma